Skip to main content

Table 2 Relationship between clinical characteristics of ovarian cancer patients and the expression of LPAR1-3

From: LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study

  Total (N) LPAR1-Positive (%) P value LPAR2- Positive (%) P value LPAR3-Positive (%) P value
  52 36 (69.23)   22 (42.31)   9 (17.31)  
Histological subtypes 0   0.664   0.587   0.542
 Serous 26 20 (76.925)   11 (42.31)   4 (15.38)  
 Mucinous 8 5 (62.5 %)   3 (37.50)   2 (25.00)  
 Endometroid 12 7 (58.33 %)   4 (33.33)   3 (25.00)  
 Clear cell/Undifferentiated 6 4 (66.67 %)   4 (66.67)   0 (0)  
Differentiation    0.415   0.002*   0.034*
 High 13 10 (76.92)   2 (15.38)   2 (15.38)  
 Moderate 20 12 (60.00)   6 (30.00)   2 (10.00)  
 Poor 19 14 (73.68)   14 (73.68)   5 (26.32)  
Clinical stage    0.003*   0.712   0.678
 FIGO I 6 1 (16.67)   3 (50.00)   2 (33.33)  
 FIGO II 8 4 (50.00)   3 (37.5)   2 (25.00)  
 FIGO III 28 21 (75.00)   12 (42.86)   4 (14.29)  
 FIGO IV 10 10 (100.00)   4 (40.00)   1 (10.00)  
  1. * P <0.05 indicates statistically significant difference